| Product Code: ETC7743878 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The market for OTC artificial tears in Japan saw a decline in import shipments from top exporting countries like USA, Germany, Switzerland, Ireland, and Sweden in 2024. Despite a low concentration in 2023, the Herfindahl-Hirschman Index (HHI) indicated even lower concentration in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was -3.67%, with a further decline in the growth rate from 2023 to 2024 at -3.17%. These trends suggest a challenging market environment for artificial tears imports in Japan.

The Japan OTC artificial tears market is experiencing steady growth driven by factors such as an aging population, increasing screen time leading to digital eye strain, and a high prevalence of dry eye syndrome. Consumers are increasingly seeking over-the-counter artificial tears as a convenient and cost-effective solution for mild to moderate dry eye symptoms. Key players in the market are focusing on product innovation, such as preservative-free formulations and advanced technology to improve lubrication and hydration of the eyes. Distribution channels play a crucial role in reaching consumers, with pharmacies and online retail platforms being popular choices for purchasing OTC artificial tears. With a strong emphasis on eye health and wellness, the Japan OTC artificial tears market is expected to continue expanding as consumers prioritize self-care and seek accessible remedies for eye discomfort.
The Japan OTC artificial tears market is witnessing a growing demand due to the increasing prevalence of dry eye syndrome among the aging population and the rise in digital device usage. Key trends in the market include the introduction of preservative-free and innovative formulations, such as gel-based and lipid-based artificial tears, to address specific patient needs. Additionally, the market is seeing a shift towards online retail channels for purchasing OTC artificial tears, offering convenience and accessibility to consumers. Opportunities exist for market players to invest in research and development to launch advanced products with longer-lasting effects and enhanced comfort. Collaboration with healthcare professionals and pharmacists for better patient education and outreach can also drive market growth in Japan`s OTC artificial tears sector.
In the Japan OTC Artificial Tears Market, some key challenges include increasing competition from a growing number of market players offering similar products, pricing pressures due to the presence of both domestic and international brands, and the need for continuous innovation to meet evolving consumer preferences. Additionally, regulatory hurdles related to the approval process for new products and ingredients can pose challenges for market entry and expansion. Ensuring effective marketing strategies to differentiate products in a crowded market and building brand trust among consumers are also critical challenges faced by companies operating in the Japan OTC Artificial Tears Market. Overall, navigating these challenges requires a deep understanding of consumer needs, strong research and development capabilities, and strategic partnerships to drive growth and success in the market.
The Japan OTC artificial tears market is primarily driven by factors such as a growing aging population, increasing prevalence of dry eye syndrome, rising awareness about eye health, and advancements in eye care technology. The aging population in Japan is more prone to dry eye syndrome, leading to a higher demand for artificial tears products available over the counter. Additionally, the increasing adoption of digital devices and screens has contributed to a rise in dry eye cases among the younger population as well. The convenience and easy availability of OTC artificial tears products in pharmacies and online platforms further fuel market growth. Moreover, the expanding healthcare infrastructure and emerging trends in self-care and preventive healthcare are expected to drive the market for artificial tears in Japan.
The Japan OTC Artificial Tears Market is subject to regulations by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. The government has implemented policies to ensure the safety, efficacy, and quality of OTC artificial tears products. These policies include requirements for product registration, labeling regulations, and adherence to Good Manufacturing Practices (GMP). Additionally, the government monitors and evaluates the market to prevent the sale of counterfeit or substandard products. Companies operating in the Japan OTC Artificial Tears Market must comply with these regulations to ensure consumer safety and maintain market integrity.
The Japan OTC artificial tears market is poised for steady growth in the coming years, driven by factors such as an aging population, increasing prevalence of dry eye syndrome, and a rise in digital device usage leading to eye strain. Consumers` growing awareness of eye health and the convenience of over-the-counter products are also expected to fuel market demand. Manufacturers are likely to focus on product innovation, such as preservative-free formulations and advanced delivery systems, to cater to evolving consumer needs. The market may also witness intensified competition among key players, leading to product differentiation and aggressive marketing strategies. Overall, the Japan OTC artificial tears market is projected to experience sustained expansion and offer opportunities for companies to capitalize on the growing demand for eye care products.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan OTC Artificial Tears Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan OTC Artificial Tears Market Revenues & Volume, 2021 & 2031F |
3.3 Japan OTC Artificial Tears Market - Industry Life Cycle |
3.4 Japan OTC Artificial Tears Market - Porter's Five Forces |
3.5 Japan OTC Artificial Tears Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Japan OTC Artificial Tears Market Revenues & Volume Share, By Container Type, 2021 & 2031F |
3.7 Japan OTC Artificial Tears Market Revenues & Volume Share, By Formulation, 2021 & 2031F |
3.8 Japan OTC Artificial Tears Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Japan OTC Artificial Tears Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan OTC Artificial Tears Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of dry eye syndrome in Japan |
4.2.2 Growing awareness about eye health and the benefits of using artificial tears |
4.2.3 Technological advancements leading to the development of innovative artificial tear products |
4.3 Market Restraints |
4.3.1 Presence of alternative treatment options such as prescription eye drops and natural remedies |
4.3.2 Regulatory challenges and stringent approval processes for new artificial tear products |
5 Japan OTC Artificial Tears Market Trends |
6 Japan OTC Artificial Tears Market, By Types |
6.1 Japan OTC Artificial Tears Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Japan OTC Artificial Tears Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Japan OTC Artificial Tears Market Revenues & Volume, By Solution, 2021- 2031F |
6.1.4 Japan OTC Artificial Tears Market Revenues & Volume, By Ointment, 2021- 2031F |
6.1.5 Japan OTC Artificial Tears Market Revenues & Volume, By Emulsion, 2021- 2031F |
6.1.6 Japan OTC Artificial Tears Market Revenues & Volume, By Gel, 2021- 2031F |
6.1.7 Japan OTC Artificial Tears Market Revenues & Volume, By Spray Solution, 2021- 2031F |
6.1.8 Japan OTC Artificial Tears Market Revenues & Volume, By Suspensions, 2021- 2031F |
6.2 Japan OTC Artificial Tears Market, By Container Type |
6.2.1 Overview and Analysis |
6.2.2 Japan OTC Artificial Tears Market Revenues & Volume, By Plastic Single Dose Container, 2021- 2031F |
6.2.3 Japan OTC Artificial Tears Market Revenues & Volume, By Plastic Multi-Dose Container, 2021- 2031F |
6.2.4 Japan OTC Artificial Tears Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Japan OTC Artificial Tears Market, By Formulation |
6.3.1 Overview and Analysis |
6.3.2 Japan OTC Artificial Tears Market Revenues & Volume, By Preservative Based, 2021- 2031F |
6.3.3 Japan OTC Artificial Tears Market Revenues & Volume, By Non-Preservative Based, 2021- 2031F |
6.4 Japan OTC Artificial Tears Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Japan OTC Artificial Tears Market Revenues & Volume, By Dry Eye Syndrome, 2021- 2031F |
6.4.3 Japan OTC Artificial Tears Market Revenues & Volume, By Allergies, 2021- 2031F |
6.4.4 Japan OTC Artificial Tears Market Revenues & Volume, By Infections, 2021- 2031F |
6.4.5 Japan OTC Artificial Tears Market Revenues & Volume, By UV and Blue Light Protection, 2021- 2031F |
6.4.6 Japan OTC Artificial Tears Market Revenues & Volume, By Contact Lens Moisture Retention, 2021- 2031F |
6.4.7 Japan OTC Artificial Tears Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Japan OTC Artificial Tears Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan OTC Artificial Tears Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Japan OTC Artificial Tears Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.5.4 Japan OTC Artificial Tears Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Japan OTC Artificial Tears Market Import-Export Trade Statistics |
7.1 Japan OTC Artificial Tears Market Export to Major Countries |
7.2 Japan OTC Artificial Tears Market Imports from Major Countries |
8 Japan OTC Artificial Tears Market Key Performance Indicators |
8.1 Number of new product launches in the Japan OTC artificial tears market |
8.2 Growth in the aging population segment in Japan |
8.3 Rate of adoption of digital marketing strategies by artificial tear manufacturers |
9 Japan OTC Artificial Tears Market - Opportunity Assessment |
9.1 Japan OTC Artificial Tears Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Japan OTC Artificial Tears Market Opportunity Assessment, By Container Type, 2021 & 2031F |
9.3 Japan OTC Artificial Tears Market Opportunity Assessment, By Formulation, 2021 & 2031F |
9.4 Japan OTC Artificial Tears Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Japan OTC Artificial Tears Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan OTC Artificial Tears Market - Competitive Landscape |
10.1 Japan OTC Artificial Tears Market Revenue Share, By Companies, 2024 |
10.2 Japan OTC Artificial Tears Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |